GENE ONLINE|News &
Opinion
Blog

2021-05-27| Special

10 Precision Oncology Companies to Look Out for

by Rajaneesh K. Gopinath
Share To
Share on facebook
Share on twitter
Share on linkedin
Cancer is a leading cause of worldwide deaths and is a huge burden on patient lifestyle. Over the years, cancer diagnosis and treatments have transitioned from finding the site of tumor origin to removal and eventually killing tumors. Today, precision oncology facilitates early cancer detection, enables targeted treatment selections, and allows the elucidation of genetic

Continue reading by subscribing to GO Prime

LATEST
Lilly Bets $2 Billion on Kumquat Biosciences for Novel Immune-Oncology Therapeutics
2021-07-31
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31
Amgen Acquires Teneobio to Snag New Class of Antibody Therapies
2021-07-31
Takeda Signs New Deal with PeptiDream Spending Billions to Develop Neuromuscular Disease Drugs
2021-07-30
The Evolution of Cytokine Therapies for a Broad Spectrum of Disorders
2021-07-30
PerkinElmer Makes its Biggest Buy Yet Forking Out $5.25 Billion for Latest Acquisition
2021-07-30
Japan’s Chugai Infuses $500 Million for a New API Manufacturing Building
2021-07-29
Scroll to Top

Subscribe To Our News

Keep yourself updated at all times!